Kelly Financial Services LLC Amgen Inc Transaction History

Kelly Financial Services LLC

$258 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $29,953 - $36,401	114 Added 47.5%	354 $110,000
Q1 2024 Jul 17, 2024	BUY	$268.87 - $324.56 $537 - $649	2 Added 0.84%	240 $68,000
Q4 2023 Jul 17, 2024	BUY	$255.7 - $288.46 $9,716 - $10,961	38 Added 19.0%	238 $68.6 Million
Q3 2023 Jul 17, 2024	SELL	$218.65 - $271.46 $4,373 - $5,429	-20 Reduced 9.09%	200 $53.6 Million
Q2 2023 Jul 17, 2024	BUY	$214.27 - $253.37 $18,641 - $22,043	87 Added 65.41%	220 $48.8 Million
Q1 2023 Jul 17, 2024	BUY	$225.79 - $275.2 $8,580 - $10,457	38 Added 40.0%	133 $32 Million
Q3 2022 Jul 17, 2024	BUY	$224.46 - $253.15 $224 - $253	1 Added 1.06%	95 $21.4 Million
Q2 2022 Jul 17, 2024	BUY	$230.71 - $256.74 $230 - $256	1 Added 1.08%	94 $22.9 Million
Q1 2022 Jul 17, 2024	BUY	$219.27 - $242.57 $219 - $242	1 Added 1.09%	93 $22.5 Million
Q3 2021 Jul 17, 2024	SELL	$212.27 - $248.7 $4.89 Million - $5.73 Million	-23,054 Reduced 99.6%	92 $19.5 Million
Q2 2021 Jul 17, 2024	BUY	$233.58 - $259.14 $5.38 Million - $5.97 Million	23,052 Added 24523.4%	23,146 $95,000
Q4 2020 Jul 17, 2024	BUY	$216.38 - $257.67 $216 - $257	1 Added 1.08%	94 $21.5 Million
Q3 2020 Jul 17, 2024	BUY	$234.65 - $260.95 $234 - $260	1 Added 1.09%	93 $23.6 Million
Q1 2020 Jul 17, 2024	BUY	$182.24 - $241.7 $182 - $241	1 Added 1.1%	92 $18.6 Million
Q4 2019 Jul 17, 2024	BUY	$189.21 - $243.2 $189 - $243	1 Added 1.11%	91 $21.9 Million
Q2 2019 Jul 17, 2024	BUY	$166.7 - $195.41 $166 - $195	1 Added 1.12%	90 $16.5 Million
Q1 2019 Jul 17, 2024	BUY	$180.87 - $203.88 $16,097 - $18,145	89 New	89 $16.9 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.

Account